Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

43.09
BATS BZX Real-Time Price
As of 1:26pm ET
 +0.30 / +0.70%
Today’s Change
31.47
Today|||52-Week Range
54.13
+10.23%
Year-to-Date
Mediation Talks Between Abbott and Alere Collapse
Sep 28 / TheStreet.com - Paid Partner Content
J&J (JNJ) to Buy Abbott's Vision Care Unit for $4.3 Billion
Sep 19 / Zacks.com - Paid Partner Content
Johnson & Johnson's Smart (Yet Surprising) Acquisition
Sep 20 / MotleyFool.com - Paid Partner Content
Abbott Labs/Alere: before and after
Sep 01 / FT.com - Paid Partner Content

Today’s Trading

Previous close42.79
Today’s open42.80
Day’s range42.63 - 43.16
Volume8,312
Average volume (3 months)998,712
Market cap$3.7B
Dividend yield--
Data as of 1:26pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-212.07%
Earnings growth (this year)-41.92%
Earnings growth (next 5 years)+8.35%
Revenue growth (last year)-4.77%
P/E ratioNM
Price/Sales1.36
Price/Book2.55

Competitors

 Today’s
change
Today’s
% change
NEOGNeogen Corp+1.22+2.26%
AAAPAdvanced Accelerator...-0.44-1.14%
MYGNMyriad Genetics Inc-0.03-0.14%
VIVOMeridian Bioscience ...-0.08-0.42%
Data as of 1:27pm ET, 09/30/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$0.53
Annual revenue (last year)$2.5B
Annual profit (last year)-$16.0M
Net profit margin-0.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Namal Nawana
Senior Vice President-
Global Operations
Mark Gladwell
Corporate headquarters
Waltham, Massachusetts

Forecasts

Search for Jobs